AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/566
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMyles, PSen_US
dc.contributor.authorBellomo, Ren_US
dc.contributor.authorCorcoran, Ten_US
dc.contributor.authorForbes, Aen_US
dc.contributor.authorPeyton, Pen_US
dc.contributor.authorStory, Den_US
dc.contributor.authorChristophi, Cen_US
dc.contributor.authorLeslie, Ken_US
dc.contributor.authorMcGuinness, Sen_US
dc.contributor.authorParke, Ren_US
dc.contributor.authorSerpell, Jen_US
dc.contributor.authorChan, MTVen_US
dc.contributor.authorPainter, Ten_US
dc.contributor.authorMcCluskey, Sen_US
dc.contributor.authorMinto, Gen_US
dc.contributor.authorWallace, Sen_US
dc.contributor.authorANZCA Clinical Trials Networken_US
dc.contributor.authorNZ Intensive Care Society Clinical Trials Groupen_US
dc.date2018-05-10-
dc.date.accessioned2018-05-10T06:04:03Z-
dc.date.available2018-05-10T06:04:03Z-
dc.date.issued2018-06-14en_US
dc.identifier.citation2018; doi:10.1056/NEJMoa1801601en_US
dc.identifier.issn0028-4793en_US
dc.identifier.urihttp://hdl.handle.net/11055/566-
dc.description.abstractBACKGROUND Guidelines to promote the early recovery of patients undergoing major surgery recommend a restrictive intravenous-fluid strategy for abdominal surgery. However, the supporting evidence is limited, and there is concern about impaired organ perfusion. METHODS In a pragmatic, international trial, we randomly assigned 3000 patients who had an increased risk of complications while undergoing major abdominal surgery to receive a restrictive or liberal intravenous-fluid regimen during and up to 24 hours after surgery. The primary outcome was disability-free survival at 1 year. Key secondary outcomes were acute kidney injury at 30 days, renal-replacement therapy at 90 days, and a composite of septic complications, surgical-site infection, or death. RESULTS During and up to 24 hours after surgery, 1490 patients in the restrictive fluid group had a median intravenous-fluid intake of 3.7 liters (interquartile range, 2.9 to 4.9), as compared with 6.1 liters (interquartile range, 5.0 to 7.4) in 1493 patients in the liberal fluid group (P<0.001). The rate of disability-free survival at 1 year was 81.9% in the restrictive fluid group and 82.3% in the liberal fluid group (hazard ratio for death or disability, 1.05; 95% confidence interval, 0.88 to 1.24; P=0.61). The rate of acute kidney injury was 8.6% in the restrictive fluid group and 5.0% in the liberal fluid group (P<0.001). The rate of septic complications or death was 21.8% in the restrictive fluid group and 19.8% in the liberal fluid group (P=0.19); rates of surgical-site infection (16.5% vs. 13.6%, P=0.02) and renal-replacement therapy (0.9% vs. 0.3%, P=0.048) were higher in the restrictive fluid group, but the between-group difference was not significant after adjustment for multiple testing. CONCLUSIONS Among patients at increased risk for complications during major abdominal surgery, a restrictive fluid regimen was not associated with a higher rate of disability-free survival than a liberal fluid regimen and was associated with a higher rate of acute kidney injury. (Funded by the Australian National Health and Medical Research Council and others; RELIEF ClinicalTrials.gov number, NCT01424150.)en_US
dc.subjectmajor surgeryen_US
dc.subjectperfusionen_US
dc.subjectrestrictive fluid regimenen_US
dc.subjectRELIEFen_US
dc.titleRestrictive versus liberal fluid therapy for major abdominal surgeryen_US
dc.typeJournal Articleen_US
dc.type.contentTexten_US
dc.identifier.journaltitleThe New England Journal of Medicineen_US
dc.identifier.doi10.1056/NEJMoa1801601en_US
dc.description.affiliatesAustralian and New Zealand College of Anaesthetistsen_US
dc.description.affiliatesAlfred Hospitalen_US
dc.description.affiliatesMonash Universityen_US
dc.description.affiliatesUniversity of Melbourneen_US
dc.description.affiliatesAustin Hospital, Heidelbergen_US
dc.description.affiliatesRoyal Perth Hospitalen_US
dc.description.affiliatesUniversity of Western Australia, Perthen_US
dc.description.affiliatesRoyal Melbourne Hospitalen_US
dc.description.affiliatesRoyal Adelaide Hospitalen_US
dc.description.affiliatesDiscipline of Acute Care Medicine, University of Adelaideen_US
dc.description.affiliatesAuckland City Hospitalen_US
dc.description.affiliatesMedical Research Institute of New Zealanden_US
dc.description.affiliatesChinese University of Hong Kongen_US
dc.description.affiliatesUniversity Health Network, Torontoen_US
dc.description.affiliatesDerriford Hospital, Plymouth, United Kingdomen_US
dc.description.pubmedurihttps://www.nejm.org/doi/full/10.1056/NEJMoa1801601en_US
dc.type.studyortrialRandom Allocationen_US
dc.identifier.studynameNCT01424150en_US
dc.ispartof.anzcaresearchfoundationYesen_US
dc.type.specialtyAnaesthesiaen_US
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Scholarly and Clinical
Show simple item record

Page view(s)

72
checked on Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.